Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of Entresto 100mg Tablets:
Entresto, also recognized by its generic name sacubitril/valsartan, is a prescribed medication utilized to address specific heart conditions. It constitutes a combination drug containing two active ingredients: sacubitril and valsartan. This medication is primarily designated for managing heart failure with reduced ejection fraction (HFrEF), a condition characterized by the heart's diminished ability to pump blood, resulting in symptoms like breathlessness, fatigue, and fluid retention. Entresto has garnered approval from regulatory agencies in multiple countries and has demonstrated significant efficacy in heart failure management.
Mechanism of Action of Entresto 100mg Tablets:
The mechanism of action of Entresto involves its two active constituents, sacubitril and valsartan, synergistically addressing distinct aspects of heart failure:
Sacubitril: Sacubitril functions as a neprilysin inhibitor. Neprilysin, an enzyme in the body, breaks down various substances, including natriuretic peptides crucial for regulating blood pressure and fluid balance. By inhibiting neprilysin, sacubitril elevates the levels of these beneficial peptides, inducing vasodilation (expansion of blood vessels) and diuresis (elimination of excess fluid via urine). This action alleviates strain on the heart and enhances its pumping efficiency.
Valsartan: Valsartan operates as an angiotensin receptor blocker (ARB). It antagonizes the effects of angiotensin II, a hormone that constricts blood vessels and elevates blood pressure. By inhibiting angiotensin II, valsartan promotes vasodilation, diminishes blood pressure, and reduces the cardiac workload.
Uses of Entresto 100mg Tablets:
The treatment of heart failure
Benefits of Entresto 100mg Tablets:
Improving Heart Function: Entresto enhances the heart's pumping capacity, facilitating improved blood circulation throughout the body.
Symptom Relief: It alleviates symptoms associated with heart failure, including dyspnea, fatigue, peripheral edema, and reduced exercise tolerance.
Reducing Hospitalizations: Entresto has demonstrated efficacy in lowering the risk of hospitalization due to exacerbations of heart failure, thereby enhancing overall quality of life for affected individuals.
Prolonging Life: Clinical investigations have suggested that Entresto may extend the lifespan of individuals with heart failure by reducing the risk of cardiovascular-related mortality.
Well-Tolerated: Generally, Entresto is well-tolerated by most individuals, with side effects typically being mild and manageable.